268 related articles for article (PubMed ID: 18364376)
1. Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis.
Cheung K; Roman SA; Wang TS; Walker HD; Sosa JA
J Clin Endocrinol Metab; 2008 Jun; 93(6):2173-80. PubMed ID: 18364376
[TBL] [Abstract][Full Text] [Related]
2. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.
Elisei R; Bottici V; Luchetti F; Di Coscio G; Romei C; Grasso L; Miccoli P; Iacconi P; Basolo F; Pinchera A; Pacini F
J Clin Endocrinol Metab; 2004 Jan; 89(1):163-8. PubMed ID: 14715844
[TBL] [Abstract][Full Text] [Related]
3. A Genomic Alternative to Identify Medullary Thyroid Cancer Preoperatively in Thyroid Nodules with Indeterminate Cytology.
Kloos RT; Monroe RJ; Traweek ST; Lanman RB; Kennedy GC
Thyroid; 2016 Jun; 26(6):785-93. PubMed ID: 26992356
[TBL] [Abstract][Full Text] [Related]
4. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases.
Hahm JR; Lee MS; Min YK; Lee MK; Kim KW; Nam SJ; Yang JH; Chung JH
Thyroid; 2001 Jan; 11(1):73-80. PubMed ID: 11272100
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.
Costante G; Meringolo D; Durante C; Bianchi D; Nocera M; Tumino S; Crocetti U; Attard M; Maranghi M; Torlontano M; Filetti S
J Clin Endocrinol Metab; 2007 Feb; 92(2):450-5. PubMed ID: 17119000
[TBL] [Abstract][Full Text] [Related]
6. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
[TBL] [Abstract][Full Text] [Related]
7. Screening for medullary thyroid carcinoma with serum calcitonin measurements in patients with thyroid nodules in the United States and Canada.
Daniels GH
Thyroid; 2011 Nov; 21(11):1199-207. PubMed ID: 21936671
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of medullary thyroid carcinoma by calcitonin measurement in fine-needle aspiration biopsy specimens.
Kudo T; Miyauchi A; Ito Y; Takamura Y; Amino N; Hirokawa M
Thyroid; 2007 Jul; 17(7):635-8. PubMed ID: 17696833
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of routine calcitonin screening and fine-needle aspiration biopsy in preoperative diagnosis of medullary thyroid Cancer in the United States.
Al-Qurayshi Z; Kandil E; Randolph GW
Oral Oncol; 2020 Nov; 110():104878. PubMed ID: 32652480
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of molecular testing for thyroid nodules with atypia of undetermined significance cytology.
Lee L; How J; Tabah RJ; Mitmaker EJ
J Clin Endocrinol Metab; 2014 Aug; 99(8):2674-82. PubMed ID: 24684467
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of a novel molecular test for cytologically indeterminate thyroid nodules.
Li H; Robinson KA; Anton B; Saldanha IJ; Ladenson PW
J Clin Endocrinol Metab; 2011 Nov; 96(11):E1719-26. PubMed ID: 21865367
[TBL] [Abstract][Full Text] [Related]
12. Medullary thyroid carcinoma in a patient with Hashimoto's thyroiditis diagnosed by calcitonin washout from a thyroid nodule.
Mousa U; Gursoy A; Ozdemir H; Moray G
Diagn Cytopathol; 2013 Jul; 41(7):644-6. PubMed ID: 22102446
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin measurement in aspiration needle washout fluids has higher sensitivity than cytology in detecting medullary thyroid cancer: a retrospective multicentre study.
Trimboli P; Cremonini N; Ceriani L; Saggiorato E; Guidobaldi L; Romanelli F; Ventura C; Laurenti O; Messuti I; Solaroli E; Madaio R; Bongiovanni M; Orlandi F; Crescenzi A; Valabrega S; Giovanella L
Clin Endocrinol (Oxf); 2014 Jan; 80(1):135-40. PubMed ID: 23627255
[TBL] [Abstract][Full Text] [Related]
14. Medullary thyroid nodules by measurement of calcitonin (Ct) in aspiration needle washout in patients with multinodular goiter and moderately elevated serum Ct.
Trimboli P; Nigri G; Romanelli F; Cicciarella Modica DD; Crescenzi A; Valabrega S; Giovanella L
Exp Clin Endocrinol Diabetes; 2012 Apr; 120(4):234-7. PubMed ID: 22328107
[TBL] [Abstract][Full Text] [Related]
15. Benefit of measuring basal serum calcitonin to detect medullary thyroid carcinoma in a Danish population with a high prevalence of thyroid nodules.
Hasselgren M; Hegedüs L; Godballe C; Bonnema SJ
Head Neck; 2010 May; 32(5):612-8. PubMed ID: 19691107
[TBL] [Abstract][Full Text] [Related]
16. Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study.
Papi G; Corsello SM; Cioni K; Pizzini AM; Corrado S; Carapezzi C; Fadda G; Baldini A; Carani C; Pontecorvi A; Roti E
J Endocrinol Invest; 2006 May; 29(5):427-37. PubMed ID: 16794366
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic value of calcitonin measurement in wash-out fluid from fine-needle aspiration of thyroid nodules in the diagnosis of medullary thyroid cancer.
Diazzi C; Madeo B; Taliani E; Zirilli L; Romano S; Granata AR; De Santis MC; Simoni M; Cioni K; Carani C; Rochira V
Endocr Pract; 2013; 19(5):769-79. PubMed ID: 23757613
[TBL] [Abstract][Full Text] [Related]
18. The value of routine measurement of serum calcitonin on insufficient, indeterminate, and suspicious thyroid nodule cytology.
Sencar ME; Hepsen S; Çalapkulu M; Bostan H; Sakiz D; Ozturk Unsal I; Duger H; Kizilgul M; Ucan B; Taskin Turkmenoglu T; Ozbek M; Cakal E
Bosn J Basic Med Sci; 2022 Feb; 22(1):118-123. PubMed ID: 34247569
[TBL] [Abstract][Full Text] [Related]
19. Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules.
Verbeek HH; de Groot JWB; Sluiter WJ; Muller Kobold AC; van den Heuvel ER; Plukker JT; Links TP
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD010159. PubMed ID: 32176812
[TBL] [Abstract][Full Text] [Related]
20. To stimulate or withdraw? A cost-utility analysis of recombinant human thyrotropin versus thyroxine withdrawal for radioiodine ablation in patients with low-risk differentiated thyroid cancer in the United States.
Wang TS; Cheung K; Mehta P; Roman SA; Walker HD; Sosa JA
J Clin Endocrinol Metab; 2010 Apr; 95(4):1672-80. PubMed ID: 20139234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
